Sanofi Book Value Per Share Growth & History (SAN)
Sanofi's book value per share was €58.53 for fiscal 2025.
View full Sanofi company overviewSanofi annual book value per share history
| Fiscal year | Period ended | Book value per share | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €58.53 | -€2.83 | −4.61% |
| 2024 | 2024-12-31 | €61.36 | €2.82 | +4.82% |
| 2023 | 2023-12-31 | €58.54 | -€0.77 | −1.31% |
| 2022 | 2022-12-31 | €59.31 | €4.96 | +9.12% |
| 2021 | 2021-12-31 | €54.36 | €3.90 | +7.73% |
| 2020 | 2020-12-31 | €50.46 | €3.36 | +7.13% |
| 2019 | 2019-12-31 | €47.10 | -€0.17 | −0.36% |
| 2018 | 2018-12-31 | €47.27 | €0.97 | +2.09% |
| 2017 | 2017-12-31 | €46.31 | €1.58 | +3.52% |
| 2016 | 2016-12-31 | €44.73 | €0.29 | +0.65% |
| 2015 | 2015-12-31 | €44.44 | — | — |
Sanofi quarterly book value per share
| Fiscal quarter | Period ended | Book value per share | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | €57.00 | -€0.02 | −0.03% |
| Q1 2026 | 2026-03-31 | €60.78 | — | — |
| Q4 2025 | 2025-12-31 | €58.53 | -€2.83 | −4.61% |
| Q3 2025 | 2025-09-30 | €60.15 | — | — |
| Q2 2025 | 2025-06-30 | €57.02 | — | — |
| Q4 2024 | 2024-12-31 | €61.36 | €2.82 | +4.82% |
| Q4 2023 | 2023-12-31 | €58.54 | -€0.77 | −1.31% |
| Q4 2022 | 2022-12-31 | €59.31 | €4.96 | +9.12% |
| Q4 2021 | 2021-12-31 | €54.36 | €3.90 | +7.73% |
| Q4 2020 | 2020-12-31 | €50.46 | — | — |
Sanofi book value per share trends
Over the last five fiscal years, Sanofi's book value per share increased from €50.46 to €58.53, a change of €8.08. The latest reported quarter, Q2 2026, shows €57.00.
What book value per share means
Book value per share estimates the common shareholders’ accounting equity represented by each share. It can help compare a company’s balance-sheet value over time, although market value can differ substantially from book value.
How book value per share is calculated
TickerStat calculates book value per share as SEC-reported common shareholders’ equity divided by reported period-end common shares. Preferred equity is subtracted when separately reported, and basic weighted-average shares are used only when period-end shares are unavailable. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Sanofi source filings ↗